The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.

The anti-gp41 virus neutralizing monoclonal antibody 2F5 was infused into chimpanzees, which were then given an intravenous challenge with a primary human immunodeficiency virus type I (HIV-1) isolate. In two control animals, the infection was established immediately, as evidenced by positive cell-a...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	J Virol
Hlavní autoři:	Conley, A J, Kessler JA, I I, Boots, L J, McKenna, P M, Schleif, W A, Emini, E A, Mark, G E, Katinger, H, Cobb, E K, Lunceford, S M, Rouse, S R, Murthy, K K
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1996
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190718/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8794312/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.10.6751-6758.1996
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.

Podobné jednotky